Antihormonal Drug Pulled in Australia Remains Available in New Zealand
Goserelin, an antihormonal medication essential for treating conditions like breast and prostate cancer, endometriosis, and uterine fibroids, remains fully available in New Zealand. While the manufacturer, AstraZeneca, is withdrawing the 3.6mg implant from the Australian market for commercial reasons, Pharmac has confirmed there are no plans to alter supply or funding arrangements for New Zealand … Read more